Published in Br J Pharmacol on January 01, 2003
Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors. Cardiovasc Res (2004) 1.60
Genetic disruption of G proteins, G(i2)alpha or G(o)alpha, does not abolish inotropic and chronotropic effects of stimulating muscarinic cholinoceptors in atrium. Br J Pharmacol (2009) 0.84
Human 5-HT₄receptor stimulation in atria of transgenic mice. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.78
Autocrine signaling via A(1) adenosine receptors causes downregulation of M(2) receptors in adult rat atrial myocytes in vitro. Pflugers Arch (2011) 0.75
The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol (1929) 23.79
Receptors for purines and pyrimidines. Pharmacol Rev (1998) 13.92
Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol (1963) 4.04
On the mechanism of activation of muscarinic K+ channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins. Pflugers Arch (1986) 2.81
Two pacemaker channels from human heart with profoundly different activation kinetics. EMBO J (1999) 2.51
Cellular expression and functional characterization of four hyperpolarization-activated pacemaker channels in cardiac and neuronal tissues. Eur J Biochem (2001) 2.47
Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res (1999) 2.37
Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res (1998) 2.19
Molecular cloning and characterization of the human A3 adenosine receptor. Proc Natl Acad Sci U S A (1993) 2.08
The parasympathetic neuroeffector junction of the heart. Pharmacol Rev (1985) 1.91
Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol (1997) 1.88
Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol (1983) 1.86
Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol (1991) 1.68
Adenosine as inhibitor of myocardial effects of catecholamines. Pflugers Arch (1977) 1.58
Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci U S A (1997) 1.41
M(3)-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am J Physiol Regul Integr Comp Physiol (2002) 1.21
Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current, I(f). Circ Res (1997) 1.14
Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP. J Pharmacol Exp Ther (1985) 1.04
Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart. Mol Pharmacol (2001) 1.03
Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts. Am J Physiol Heart Circ Physiol (2000) 1.02
Quantitation of mRNAs for M(1) to M(5) subtypes of muscarinic receptors in rat heart and brain cortex. Mol Pharmacol (2002) 1.01
Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect. J Pharmacol Exp Ther (1984) 1.00
Regional expression of phospholamban in the human heart. Cardiovasc Res (1999) 0.98
Transgenic overexpression of cardiac A(1) adenosine receptors mimics ischemic preconditioning. Am J Physiol Heart Circ Physiol (2000) 0.98
Role of guanine nucleotide-binding protein in the regulation by adenosine of cardiac potassium conductance and force of contraction. Evaluation with pertussis toxin. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.97
The pacemaker current I(f) in single human atrial myocytes and the effect of beta-adrenoceptor and A1-adenosine receptor stimulation. Br J Pharmacol (1997) 0.95
In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist. Eur J Pharmacol (1996) 0.95
Adenosine release by the isolated guinea pig heart in response to isoproterenol, acetylcholine, and acidosis: the minimal role of vascular endothelium. Circ Res (1987) 0.93
Characterization of A1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circ Res (1989) 0.90
Functional evidence for the existence of adenosine receptors in the human heart. Eur J Pharmacol (1985) 0.88
Transgenic A1 adenosine receptor overexpression markedly improves myocardial energy state during ischemia-reperfusion. J Mol Cell Cardiol (1998) 0.87
Cardioprotection by K(ATP) channels in wild-type hearts and hearts overexpressing A(1)-adenosine receptors. Am J Physiol Heart Circ Physiol (2000) 0.85
Modulation of the hyperpolarization-activated current (I(f)) by adenosine in rabbit sinoatrial myocytes. Circulation (1996) 0.85
Altered cardiovascular responses in mice lacking the M(1) muscarinic acetylcholine receptor. J Pharmacol Exp Ther (2002) 0.85
Inhibition of the effects of adenosine on force of contraction and the slow calcium inward current by pertussis toxin is associated with myocardial lesions. Cardiovasc Res (1988) 0.84
Adenosine reduces catecholamine contractile responses in oxygenated and hypoxic atria. Am J Physiol (1983) 0.83
Characterization of biochemical effects of CGS 21680C, an A2-adenosine receptor agonist, in the mammalian ventricle. J Cardiovasc Pharmacol (1997) 0.81
Effects of adenosine receptor and muscarinic cholinergic receptor agonists on cardiac protein phosphorylation. Influence of pertussis toxin. J Pharmacol Exp Ther (1994) 0.81
Functional studies in atrium overexpressing A1-adenosine receptors. Br J Pharmacol (1999) 0.79
Dual effect of nitric oxide on the hyperpolarization-activated inward current (I(f)) in sino-atrial node cells of the rabbit. J Mol Cell Cardiol (1998) 0.79
Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. J Clin Invest (2009) 3.45
Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol (2008) 2.37
Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation (2006) 2.00
Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics (2009) 1.77
Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation (2009) 1.72
Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors. Cardiovasc Res (2004) 1.60
Effect of cardiac A(1) adenosine receptor overexpression on sarcoplasmic reticulum function. Cardiovasc Res (2002) 1.46
Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function. J Biol Chem (2004) 1.24
Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart. J Am Heart Assoc (2013) 1.18
Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. Am J Physiol Heart Circ Physiol (2005) 1.17
Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes. FASEB J (2003) 1.13
Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Blood (2010) 1.11
Impaired relaxation in transgenic mice overexpressing junctin. Cardiovasc Res (2003) 1.10
On the role of junctin in cardiac Ca2+ handling, contractility, and heart failure. Am J Physiol Heart Circ Physiol (2007) 1.09
Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J Mol Cell Cardiol (2008) 1.09
Mutational spectrum in the Ca(2+)--activated cation channel gene TRPM4 in patients with cardiac conductance disturbances. Hum Mutat (2011) 1.07
Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ Arrhythm Electrophysiol (2010) 1.05
Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2. Cardiovasc Res (2005) 1.03
Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload. Cardiovasc Res (2008) 1.01
Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice. J Biol Chem (2004) 1.00
Protein phosphatase 2A affects myofilament contractility in non-failing but not in failing human myocardium. J Muscle Res Cell Motil (2011) 1.00
A proteasome inhibitor confers cardioprotection. Cardiovasc Res (2002) 0.99
Cardiac overexpression of A1-adenosine receptor protects intact mice against myocardial infarction. Am J Physiol Heart Circ Physiol (2002) 0.98
Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists. Cardiovasc Res (2004) 0.97
Altered sinus nodal and atrioventricular nodal function in freely moving mice overexpressing the A1 adenosine receptor. Am J Physiol Heart Circ Physiol (2003) 0.96
Overexpression of junctin causes adaptive changes in cardiac myocyte Ca(2+) signaling. Cell Calcium (2005) 0.94
Impaired cardiac contraction and relaxation and decreased expression of sarcoplasmic Ca2+-ATPase in mice lacking the CREM gene. FASEB J (2002) 0.94
Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.94
Mechanical unloading of the rat heart involves marked changes in the protein kinase-phosphatase balance. J Mol Cell Cardiol (2008) 0.93
Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice. Int J Cardiol (2011) 0.93
Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart. J Cardiovasc Pharmacol (2002) 0.93
Gastroprotection by vitamin C--a heme oxygenase-1-dependent mechanism? Biochem Biophys Res Commun (2003) 0.92
Promotion of physical activity for children and adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation (2013) 0.92
Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice. Cardiovasc Res (2002) 0.91
Genetic modulation of adenosine receptor function and adenosine handling in murine hearts: insights and issues. J Mol Cell Cardiol (2006) 0.89
Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression. J Physiol (2003) 0.89
Cardiomyocyte-specific inactivation of transcription factor CREB in mice. FASEB J (2007) 0.88
A positive inotropic effect of ATP in the human cardiac atrium. Am J Physiol Heart Circ Physiol (2008) 0.88
Proarrhythmia in a non-failing murine model of cardiac-specific Na+/Ca 2+ exchanger overexpression: whole heart and cellular mechanisms. Basic Res Cardiol (2012) 0.88
Junctional sarcoplasmic reticulum transmembrane proteins in the heart. Basic Res Cardiol (2002) 0.88
A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity. Am J Physiol Heart Circ Physiol (2003) 0.86
Endogenous diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate in human myocardial tissue. Hypertension (2004) 0.85
Adenosine receptor-mediated coronary vascular protection in post-ischemic mouse heart. Life Sci (2005) 0.85
Age-dependent biochemical and contractile properties in atrium of transgenic mice overexpressing junctin. Am J Physiol Heart Circ Physiol (2004) 0.85
Critical role of transcription factor cyclic AMP response element modulator in beta1-adrenoceptor-mediated cardiac dysfunction. Circulation (2008) 0.85
An in situ evidence for autocrine function of NO in the vasculature. Nitric Oxide (2004) 0.84
Biochemical mechanisms of hibernation and stunning in the human heart. Cardiovasc Res (2002) 0.84
Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. Am J Physiol Heart Circ Physiol (2008) 0.84
Ischemic preconditioning by unstable angina reduces the release of CK-MB following CABG and stimulates left ventricular HSP-72 protein expression. J Card Surg (2005) 0.84
Protecting the heart of the American athlete: proceedings of the American College of Cardiology Sports and Exercise Cardiology Think Tank October 18, 2012, Washington, DC. J Am Coll Cardiol (2014) 0.83
The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling. J Mol Cell Cardiol (2010) 0.83
A novel intronic promoter of the Crem gene induces small ICER (smICER) isoforms. FASEB J (2013) 0.82
Development of a colorimetric and a fluorescence phosphatase-inhibitor assay suitable for drug discovery approaches. J Biomol Screen (2013) 0.81
Ischemic and pharmacological preconditioning induces further delayed protection in transgenic mouse cardiac myocytes over-expressing adenosine A1 receptors (A1AR): role of A1AR, iNOS and K(ATP) channels. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.81
Comparison of contractile responses in isolated mouse aorta and pulmonary artery: Influence of strain and sex. J Cardiovasc Pharmacol (2006) 0.81
Stress and high heart rate provoke ventricular tachycardia in mice expressing triadin. J Mol Cell Cardiol (2007) 0.81
Compartmentalization of NO signaling cascade in skeletal muscles. Biochem Biophys Res Commun (2005) 0.80
Protein phosphatase 2A is regulated by protein kinase Cα (PKCα)-dependent phosphorylation of its targeting subunit B56α at Ser41. J Biol Chem (2013) 0.80
Modulation of SR Ca2+ release by the triadin-to-calsequestrin ratio in ventricular myocytes. Am J Physiol Heart Circ Physiol (2012) 0.80
Triadin is a critical determinant of cellular Ca cycling and contractility in the heart. Am J Physiol Heart Circ Physiol (2007) 0.80
Effects of A1 adenosine receptor stimulation on the expression of genes involved in calcium homeostasis. J Mol Cell Cardiol (2005) 0.80
Percutaneous device closure of atrial septal defect in a premature infant with rapid improvement in pulmonary status. Pediatrics (2007) 0.79
Design of new beta1-selective adrenoceptor ligands as potential radioligands for in vivo imaging. Bioorg Med Chem (2003) 0.79
Autonomic dysfunction in patients with Brugada syndrome: further biochemical evidence of altered signaling pathways. Pacing Clin Electrophysiol (2011) 0.79
Transesophageal echocardiographic guidance for surgical repair of aortic insufficiency in congenital heart disease. J Am Soc Echocardiogr (2007) 0.79
Cardiac overexpression of the human 5-HT4 receptor in mice. Am J Physiol Heart Circ Physiol (2010) 0.78
Modulation of ischaemic contracture in mouse hearts: a 'supraphysiological' response to adenosine. Exp Physiol (2006) 0.78
A positive inotropic effect of adenosine in cardiac preparations of right atria from diseased human hearts. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.78
Nitric oxide synthase in muscular dystrophies: a re-evaluation. Acta Neuropathol (2006) 0.78
Altered function in atrium of transgenic mice overexpressing triadin 1. Am J Physiol Heart Circ Physiol (2002) 0.78
Human 5-HT₄receptor stimulation in atria of transgenic mice. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.78
Reduced expression of Ca2+-regulating proteins in the upper gastrointestinal tract of patients with achalasia. World J Gastroenterol (2006) 0.77
Sarcoplasmic reticulum Ca2+ release in neonatal rat cardiac myocytes. J Mol Cell Cardiol (2011) 0.77
Expression and functional role of serine/threonine phosphatases in rat esophagus. Med Sci Monit (2004) 0.77
Altered signal transduction in cardiac ventricle overexpressing A(1)-adenosine receptors. Cardiovasc Res (2003) 0.77
Cardiovascular magnetic resonance of pulmonary artery growth and ventricular function after Norwood procedure with Sano modification. J Cardiovasc Magn Reson (2008) 0.77
Myocardial function following cold ischemic storage is improved by cardiac-specific overexpression of A1-adenosine receptors. Can J Physiol Pharmacol (2005) 0.76